Biora Therapeutics is a cutting-edge brand at the forefront of therapeutic delivery innovation. They specialize in developing smart-pill technologies that ensure precise and safe administration of medications. With the aim of improving patient outcomes, Biora Therapeutics offers two advanced platforms: NaviCap™ for targeted oral delivery and BioJet™ for systemic oral delivery.

The NaviCap™ platform enables treatment at the site of disease in the gastrointestinal tract, which is particularly beneficial for patients with inflammatory bowel disease. On the other hand, the BioJet™ platform provides needle-free, oral delivery of large molecules, making it a valuable alternative to injections for managing chronic diseases. Biora Therapeutics has gained recognition for its advancements, and they periodically release press updates to keep the public informed.

Additionally, the brand actively publishes scientific evaluations and research on the effectiveness of their drug delivery systems. Overall, Biora Therapeutics revolutionizes therapeutic delivery, ensuring the right dose reaches the right place, resulting in better patient care and improved treatment outcomes